| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/07/2014 | US8623866 Nitrogen containing heteroaryl compounds |
| 01/07/2014 | US8623848 Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623374 Method for enhancing immune response with peptide |
| 01/07/2014 | CA2735934C Method of treatment of attention deficit/hyperactivity disorder (adhd) |
| 01/07/2014 | CA2636618C Oral s-adenosylmethionine compositions |
| 01/07/2014 | CA2629988C Pharmaceutical composition for the treatment of acute disorders |
| 01/07/2014 | CA2587248C Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 01/07/2014 | CA2570614C Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 01/07/2014 | CA2542504C Lipids containing omega-3 and omega-6 fatty acids |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2427896C Carrier vectors through an epithelium with tight junctions |
| 01/03/2014 | WO2014004902A2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| 01/03/2014 | WO2014004676A1 Use of faah inhibitors as neuroprotective agents in the cns |
| 01/03/2014 | WO2014004465A1 Targeted therapeutics |
| 01/03/2014 | WO2014003605A1 Treatment method for relapsing-remitting multiple sclerosis |
| 01/03/2014 | WO2014003154A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | WO2014002599A1 Crude-drug-containing pharmaceutical composition |
| 01/03/2014 | WO2014002553A1 Aripiprazole oral pharmaceutical preparation |
| 01/03/2014 | WO2014002039A1 Amphetamine prodrugs |
| 01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | WO2014001742A1 Advanced glycation end product analogues |
| 01/03/2014 | WO2014001464A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | WO2014001427A1 Nalmefene for reduction of alcohol consumption in specific target populations |
| 01/03/2014 | WO2014001377A1 5-azaindazole compounds and methods of use |
| 01/03/2014 | WO2014001348A1 Alkaloid derivatives of cytisine used in the treatment of diseases of the central nervous system |
| 01/03/2014 | WO2014001282A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001281A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001280A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001279A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001278A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001228A1 Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
| 01/03/2014 | WO2014000694A1 Phendioxin heterocycle derivative |
| 01/03/2014 | WO2014000629A1 Hexahydropentaleno derivatives, preparation method and use in medicine thereof |
| 01/03/2014 | WO2014000452A1 Traditional chinese medicine compound gel for external treatment of cancer pain and preparation method for same |
| 01/03/2014 | WO2014000029A1 Compositions and methods for reducing frequency and/or severity of headache |
| 01/03/2014 | WO2013166413A3 Compositions and methods for increasing neurotrophic peptides |
| 01/03/2014 | WO2013124817A3 MicroRNAS FOR THE GENERATION OF ASTROCYTES |
| 01/03/2014 | WO2013124816A3 Generation of neural stem cells and motor neurons |
| 01/03/2014 | WO2013000651A8 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/03/2014 | WO2012145737A8 Fatty acid amide hydrolase inhibitors for treating pain |
| 01/03/2014 | CA2877953A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | CA2877886A1 Targeted therapeutics |
| 01/03/2014 | CA2877589A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | CA2877022A1 Compositions and methods for reducing frequency and/or severity of headache |
| 01/03/2014 | CA2876780A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | CA2876778A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | CA2875797A1 Treatment method for relapsing-remitting multiple sclerosis |
| 01/02/2014 | US20140005156 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004172 Liposomes active in-vivo on neurodegenerative diseases |
| 01/02/2014 | US20140004136 Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/01/2014 | EP2679681A1 Fc riib-specific fc antibody |
| 01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 01/01/2014 | EP2679585A1 Glycine transport inhibitor |
| 01/01/2014 | EP2679580A1 Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin |
| 01/01/2014 | EP2679578A2 Preparation method and crystalline form of optical enantiomers of modafinil |
| 01/01/2014 | EP2679577A2 Preparation methods of crystalline forms of optical enantiomers of modafinil and pharmaceutical composition therof |
| 01/01/2014 | EP2679576A2 Preparation methods of forms of optical enantiomers of modafinil and pharmaceutical composition thereof |
| 01/01/2014 | EP2679220A1 Controlled porous osmotic pump tablet and the preparation method thereof |
| 01/01/2014 | EP2678327A1 Heteroaryl derivatives as alpha7 nachr modulators |
| 01/01/2014 | EP2678317A1 Benzamide derivatives as p2x7 receptor antagonists |
| 01/01/2014 | EP2678315A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR |
| 01/01/2014 | EP2678026A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 01/01/2014 | EP2678017A2 Asymmetric ureas and medical uses thereof |
| 01/01/2014 | EP2678009A1 Cystamine analogues for the treatment of parkinson's disease |
| 01/01/2014 | EP2678008A1 Nanomedicines for early nerve repair |
| 01/01/2014 | CN103492565A FcgRIIb-specific Fc antibody |
| 01/01/2014 | CN103492374A Pyrazolidin-3-one derivatives |
| 01/01/2014 | CN103492373A Ethynyl derivatives as positive allosteric modulators of the MGLUR5 |
| 01/01/2014 | CN103491976A Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 01/01/2014 | CN103491974A Method for increasing neprilysin expression and activity |
| 01/01/2014 | CN103491954A Use of L-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function |
| 01/01/2014 | CN103491949A Tablet-type composition for oral administration and method for producing same |
| 01/01/2014 | CN103484519A Wheat protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484518A Walnut protein peptide, preparation method and application thereof |
| 01/01/2014 | CN103484432A Induction medium for inducing neural stem/progenitor cells to be differentiated into oligodendrocyte precursor cells and induction method and application thereof |
| 01/01/2014 | CN103484431A Amplification culture medium of oligodendrocyte precursor cells, and amplification method and application of amplification culture medium |
| 01/01/2014 | CN103484341A Formula and production method of lucid ganoderma wine for supplementing and benefiting brain |
| 01/01/2014 | CN103484337A Formula and production method of pilose antler wine for improving intelligence and strengthening brain |
| 01/01/2014 | CN103484336A Formula and production method of pilose antler wine for invigorating blood circulation and nourishing heart |
| 01/01/2014 | CN103484334A Formula and production method of ginseng wine for supplementing and benefiting brain |
| 01/01/2014 | CN103484333A Formula and production method of brain-strengthening and tranquillizing ginseng wine |
| 01/01/2014 | CN103484318A Kidney-strengthening and tranquillizing liquor |
| 01/01/2014 | CN103484317A Milkvetch root-Chinese magnoliavine fruit liquor |
| 01/01/2014 | CN103484284A Sleep-assisting grape wine |
| 01/01/2014 | CN103484283A Honey pollen nourishing grape wine |
| 01/01/2014 | CN103483487A Novel structure product, preparation method and use of styrenic resin |
| 01/01/2014 | CN103483458A New technology for extracting polysaccharides from Lentinus edodes stems |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483335A Columbamine II derivatives and preparation method and application thereof |
| 01/01/2014 | CN103483234A Cyclopropyl amine derivatives |
| 01/01/2014 | CN103483226A Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto |
| 01/01/2014 | CN103483194A 2-fuloro fumarate (formula I), and preparation method and application thereof |
| 01/01/2014 | CN103479998A Pegylated a beta FAB |
| 01/01/2014 | CN103479993A Chinese patent medicine for treating heart diseases |
| 01/01/2014 | CN103479992A Traditional Chinese medicine pill for treating anxiety neurosis accompanied with digestive tract symptom and preparation method thereof |
| 01/01/2014 | CN103479991A Traditional Chinese medicine pill for treating dysphoria and sleeplessness and preparation method of pill |